Long-term effect of discontinuing anticholinesterase treatment on cognitive decline and mortality in Alzheimer's disease in France: a quasi-experiment and target trial emulation study
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Authors
- Thomas Nédelec (ORCID: https://orcid.org/0000-0002-9310-2879)
- Simon Lecerf
- Thibaud Lebouvier
- Octave Guinebretiere
- Stanley Durrleman
- Raphaël Bentegeac
- Julien Dumurgier
- Estelle Aymes
- Chaymae Mekkaoui
- Philippe Amouyel
- Victoria Gauthier
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Université Paris Cité (FR)
- Université de Lille (FR)
- Institut Pasteur de Lille (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- Sorbonne Université (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Fernand-Widal (FR)
- Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR)
Publication Details
- Journal
- The Lancet Regional Health - Europe
- Published
- 2026-02-12
- DOI
- https://doi.org/10.1016/j.lanepe.2026.101607
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00